image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

SigmaRoc - Director buying again

June 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SRC
  • Price:
  • 62.5p
For the third time in four months SigmaRoc has said trading is ahead of expectations. Q1 has seen slightly higher than expected volumes, while cost management and asset enhancement programs underpin margin growth. The group has completed its third acquisition, a speciality retaining wall systems business for an undisclosed sum on 2.9x EBITDA before synergies. The first two, comprising a ready-mix concrete business in Belgium and dolomitic limestone supplier, had cost a combined £12m and were acquired on EBITDA multiples of 5x and 6x, respectively. The chairman has also acquired another 115,000 shares at 58p while Lombard Odier have increased their holding from 2.2% to 5%. Even after the mini rally the shares still look chea ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author